Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Parathyroid Hormone Testing Guidelines

Primary Diagnostic Codes and Testing Recommendations

  • The primary ICD-10 codes that support medical necessity for parathyroid hormone (PTH) testing include those related to chronic kidney disease (CKD) stages 3b-5, primary hyperparathyroidism, and disorders of calcium metabolism, according to the Kidney International guidelines 1, 2
  • PTH testing is recommended at least once in adults with GFR <45 ml/min per 1.73 m² (CKD stages 3b-5) by the Kidney International guidelines 1, 2
  • For patients with elevated PTH above the upper normal limit, evaluation should first focus on hyperphosphatemia, hypocalcemia, and vitamin D deficiency, as recommended by the Kidney International guidelines 1, 2
  • PTH testing is indicated for patients with hypercalcemia to distinguish primary hyperparathyroidism from other causes, according to the American College of Cardiology guidelines 3, 4
  • Normocalcemic primary hyperparathyroidism diagnosis relies on elevated PTH with normal calcium values, as stated in the Endocrine Reviews guidelines 5

Important Testing Considerations

  • PTH is more stable in EDTA plasma than in serum, and has a circadian rhythm that may affect results depending on sampling time, according to the Endocrine Reviews guidelines 5, 6
  • Storage conditions affect stability, with PTH being more stable at 4°C than at room temperature, as recommended by the Endocrine Reviews guidelines 6
  • Different assay generations can yield PTH concentration variations, and second-generation assays measure both full-length PTH and fragments, while third-generation assays measure only full-length PTH, according to the Endocrine Reviews guidelines 5, 7, 8
  • Patient-specific factors that may affect results include race, age, BMI, and vitamin D status, as stated in the Endocrine Reviews guidelines 6

Common Pitfalls and Interferences

  • Biotin supplements can interfere with PTH assays, causing either overestimation or underestimation, according to the Endocrine Reviews guidelines 6
  • Lack of standardization between different PTH assays can lead to significant differences in results between laboratories, as noted in the Endocrine Reviews guidelines 9
  • Reference values vary based on vitamin D status, BMI, race, age, and the specific assay used, according to the Endocrine Reviews guidelines 6